How can we help?
Get in touch
Dr Targe is a consultant in Chronic Pain Medicine with an extensive experience in managing patients with complex chronic pain conditions. Dr Targe possesses clinical expertise in managing pain conditions including but not limited to neck, thoracic, low back pain, sciatica, Joint pain including, shoulder, hip and knee, Coccygeal pain, Neuropathic pain and CRPS.
He routinely performs spinal nerve and facet joint injections followed by radio-frequency denervation procedures to provide long lasting relief. Dr Targe uses ultrasound or X-ray guidance to ensure the precise and optimal placement of therapeutic agents which can provide significant relief for patients with intractable pain. He performs around 600 pain procedures annually and consults more than 600 patients with chronic pain condition per year. Additionally, he encourages the incorporation of complementary therapies, including physical therapy, cognitive-behavioural therapy, and mindfulness-based practices, which have shown great promise in improving pain outcomes and enhancing quality of life.
Dr Targe proudly serves the community as a Consultant in chronic pain medicine at East and North Hertfordshire NHS Trust. Before that he worked as a Consultant in pain medicine at Ashford and St Peter’s Hospital in Surrey and George Eliot Hospital in Midlands. He completed his pain fellowship from United Hospitals of Leicestershire NHS Trust and was awarded Fellowship in Pain Medicine( FFPMRCA) by the Faculty of Pain Medicine of the Royal College of Anaesthesia in 2021. Dr Targe underwent Anaesthetic, Intensive and Pain medicine training at East Midland school of Anaesthesia and was awarded Fellowship of Royal College of Anaesthetist in 2016. He has a degree in MBBS and MD (Anesthesiology) from India, prior to moving to the UK.
Dr Targe firmly believes that effective pain management goes beyond addressing physical symptoms. He approaches each patient as a unique individual, recognizing that chronic pain is often intertwined with psychological, social, and emotional factors. By incorporating the biopsychosocial model, he strives to understand the broader context of a patient’s pain, including their lifestyle, mental health, and social environment. This comprehensive perspective enables Dr Targe to tailor treatment plans that not only alleviate pain but also enhance overall well-being.
The field of chronic pain management has seen significant advancements in recent years, particularly in the development of novel pharmacological and non-pharmacological interventions. Dr Targe remains at the forefront of these developments, continually updating his knowledge and clinical practice to incorporate the latest evidence-based treatments. His expertise includes the use of new-generation analgesics, neuromodulators, and adjuvant therapies that offer improved efficacy and reduced side effects.
In addition to his clinical work, Dr Targe is deeply committed to the ongoing education of both himself and his colleagues. He actively participates in clinical governance and professional development activities, contributing to the growing body of knowledge in chronic pain management. He teaches regularly on courses on Ultrasound guided Pain management.
As a Chronic Pain Medicine Consultant, Dr Targe’s goal is to deliver comprehensive, compassionate, and cutting-edge care to individuals suffering from chronic pain. By embracing a holistic approach and integrating the latest advances in both pharmacological and non-pharmacological treatments, he is confident in his ability to make a meaningful difference in the lives of his patients.
Educational Supervisor for Anaesthesia and Chronic Pain Medicine and ENH NHS trust
1. Intravenous clonidine for suppression of haemodynamic response to laparoscopy- a prospective randomised, placebo controlled, single centre study
International Journal of Advances in Medicine
Int J Adv Med. 2017 Jun;4(3):788-792
2. Author of a chapter in an International publication (Book)
“Advances in Chronic and Neuropathic pain- Pharmacologic
management of Neuropathic pain”
DOI: 10.1007/978-3-031-10687-3_15